🔴 SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits European Society of Cardiology Journals #CardioEd #Cardiology #CardioTwitter

Aficamten for the treatment of symptomatic obstructive hypertrophic #cardiomyopathy - SEQUOIA-HCM study.

#HeartFailure2024 #HFA_ESC

Here are the primary results of #aficamten in NEJM

nejm.org/doi/full/10.10…

#HeartFailure2024 #CardioTwitter

🔴EXCELLENT👇👇
📌Identification of three mechanistic pathways for iron-deficient HF

1️⃣meaningful systemic iron deficiency (typically TSAT <~ 15%-16% with anaemia) results in cardiomyocyte iron deficiency and dysfunction
👉↗️ in iron influx proteins and ↘️ in iron efflux

🆕 Valvulopatías agudas: Cómo afrontar la emergencia.

📕 Cardiol Clin
📌 Via Edgardo Alania
📁 cardioteca.com/cardiologia-cl…

2024 Hypertrophic Cardiomyopathy
Guideline-at-a-Glance

🎾🤾‍♂️ Encouraging exercise for HCM patients
📁 jacc.org/doi/10.1016/j.… JACC Journals